Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
A few disorders have some of the same symptoms as schizophrenia including schizoaffective disorders, schizophreniform disorder, schizotypal and schizoid personality disorders, delusional disorder, and autism (schizophrenia spectrum disorders). Since the 2000 there has been significant progress in our understanding of the early presentations, assessment, suspected neuropathology, and treatment of these disorders. Recent technological breakthroughs in basic sciences hold promise for advancing our understanding of the pathophysiology of schizophrenia spectrum disorders. This collective monograph…mehr
A few disorders have some of the same symptoms as schizophrenia including schizoaffective disorders, schizophreniform disorder, schizotypal and schizoid personality disorders, delusional disorder, and autism (schizophrenia spectrum disorders). Since the 2000 there has been significant progress in our understanding of the early presentations, assessment, suspected neuropathology, and treatment of these disorders. Recent technological breakthroughs in basic sciences hold promise for advancing our understanding of the pathophysiology of schizophrenia spectrum disorders. This collective monograph reviewers recent researches regarding the origins, onset, course, and outcome of schizophrenia spectrum disorders. In particular, this book will be illustrate new developments in terms of conceptual models, and research methodology, genetics and genomics, brain imaging and neurochemical studies, neurophysiology and information processing in schizophrenia spectrum disorders patients. Also will be highlighted new developments in our understanding of the childhood psychosis, prodromal and first-episode states, in treatment and rehabilitation. Thus, the purpose of this book is to provide up-to-date overview of the rapid advances made in the clinical and basic science studies supporting our understanding of the relationship between cerebral processes and clinical, cognitive and other presentations of the schizophrenia spectrum disorders. In addition, this book aims to monitor important research developments, which may be relevant to treatment, and rehabilitation of patients.
Foreword. Schizophrenia Spectrum Disorders: Insights from views across 100 years. -1.Recovery in schizophrenia: perspectives, evidence, and implications. -2.The magic shotgun: does it fit the clinician and will it point at schizophrenia? -3.Advancing neuroprotective-based treatments for schizophrenia. -4.Prevention and early intervention in at risk states for developing psychosis. -5.Early improvement and its predictive validity in first-episode schizophrenia patients. -6.Antioxidants as a treatment and prevention of tardive dyskinesia. -7.Electrophysiological imaging evaluation of schizophrenia and treatment response. -8.Coping with schizophrenia: measuring coping styles, patterns and temporal types. -9.Interventions targeting social and vocational dysfunction in individuals with a schizophrenia spectrum disorder. -10.Revisiting cognitive remediation for schizophrenia: Facing the challenges of the future. -11.Individual psychotherapy for schizophrenia: an overview of its history, recent developments and new directions. -12.An overview of cognitive behavior therapy in schizophrenic spectrum disorders. -13.Schizophrenia and medical illness: consequences of schizophrenia or its treatment? -14.The interface of cannabis misuse and schizophrenia-spectrum disorders. -15.Schizophrenia and comorbid substance abuse – pathophysiological and therapeutic approaches. -16.Suicidality and outcome in schizophrenia patients.-17.The relationship between religiousness/spirituality and schizophrenia: implications for treatment and community support. -18.The ethical ramifications of biomarker use for mood disorders. -Afterword. The future of the schizophrenia construct and acquisition of new knowledge.
Foreword. Schizophrenia Spectrum Disorders: Insights from views across 100 years. -1.Recovery in schizophrenia: perspectives, evidence, and implications. -2.The magic shotgun: does it fit the clinician and will it point at schizophrenia? -3.Advancing neuroprotective-based treatments for schizophrenia. -4.Prevention and early intervention in at risk states for developing psychosis. -5.Early improvement and its predictive validity in first-episode schizophrenia patients. -6.Antioxidants as a treatment and prevention of tardive dyskinesia. -7.Electrophysiological imaging evaluation of schizophrenia and treatment response. -8.Coping with schizophrenia: measuring coping styles, patterns and temporal types. -9.Interventions targeting social and vocational dysfunction in individuals with a schizophrenia spectrum disorder. -10.Revisiting cognitive remediation for schizophrenia: Facing the challenges of the future. -11.Individual psychotherapy for schizophrenia: an overview of its history, recent developments and new directions. -12.An overview of cognitive behavior therapy in schizophrenic spectrum disorders. -13.Schizophrenia and medical illness: consequences of schizophrenia or its treatment? -14.The interface of cannabis misuse and schizophrenia-spectrum disorders. -15.Schizophrenia and comorbid substance abuse - pathophysiological and therapeutic approaches. -16.Suicidality and outcome in schizophrenia patients.-17.The relationship between religiousness/spirituality and schizophrenia: implications for treatment and community support. -18.The ethical ramifications of biomarker use for mood disorders. -Afterword. The future of the schizophrenia construct and acquisition of new knowledge.
Foreword. Schizophrenia Spectrum Disorders: Insights from views across 100 years. -1.Recovery in schizophrenia: perspectives, evidence, and implications. -2.The magic shotgun: does it fit the clinician and will it point at schizophrenia? -3.Advancing neuroprotective-based treatments for schizophrenia. -4.Prevention and early intervention in at risk states for developing psychosis. -5.Early improvement and its predictive validity in first-episode schizophrenia patients. -6.Antioxidants as a treatment and prevention of tardive dyskinesia. -7.Electrophysiological imaging evaluation of schizophrenia and treatment response. -8.Coping with schizophrenia: measuring coping styles, patterns and temporal types. -9.Interventions targeting social and vocational dysfunction in individuals with a schizophrenia spectrum disorder. -10.Revisiting cognitive remediation for schizophrenia: Facing the challenges of the future. -11.Individual psychotherapy for schizophrenia: an overview of its history, recent developments and new directions. -12.An overview of cognitive behavior therapy in schizophrenic spectrum disorders. -13.Schizophrenia and medical illness: consequences of schizophrenia or its treatment? -14.The interface of cannabis misuse and schizophrenia-spectrum disorders. -15.Schizophrenia and comorbid substance abuse – pathophysiological and therapeutic approaches. -16.Suicidality and outcome in schizophrenia patients.-17.The relationship between religiousness/spirituality and schizophrenia: implications for treatment and community support. -18.The ethical ramifications of biomarker use for mood disorders. -Afterword. The future of the schizophrenia construct and acquisition of new knowledge.
Foreword. Schizophrenia Spectrum Disorders: Insights from views across 100 years. -1.Recovery in schizophrenia: perspectives, evidence, and implications. -2.The magic shotgun: does it fit the clinician and will it point at schizophrenia? -3.Advancing neuroprotective-based treatments for schizophrenia. -4.Prevention and early intervention in at risk states for developing psychosis. -5.Early improvement and its predictive validity in first-episode schizophrenia patients. -6.Antioxidants as a treatment and prevention of tardive dyskinesia. -7.Electrophysiological imaging evaluation of schizophrenia and treatment response. -8.Coping with schizophrenia: measuring coping styles, patterns and temporal types. -9.Interventions targeting social and vocational dysfunction in individuals with a schizophrenia spectrum disorder. -10.Revisiting cognitive remediation for schizophrenia: Facing the challenges of the future. -11.Individual psychotherapy for schizophrenia: an overview of its history, recent developments and new directions. -12.An overview of cognitive behavior therapy in schizophrenic spectrum disorders. -13.Schizophrenia and medical illness: consequences of schizophrenia or its treatment? -14.The interface of cannabis misuse and schizophrenia-spectrum disorders. -15.Schizophrenia and comorbid substance abuse - pathophysiological and therapeutic approaches. -16.Suicidality and outcome in schizophrenia patients.-17.The relationship between religiousness/spirituality and schizophrenia: implications for treatment and community support. -18.The ethical ramifications of biomarker use for mood disorders. -Afterword. The future of the schizophrenia construct and acquisition of new knowledge.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG i.I. Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
